JPH01227964A - Production of immunological analysis element - Google Patents
Production of immunological analysis elementInfo
- Publication number
- JPH01227964A JPH01227964A JP5558988A JP5558988A JPH01227964A JP H01227964 A JPH01227964 A JP H01227964A JP 5558988 A JP5558988 A JP 5558988A JP 5558988 A JP5558988 A JP 5558988A JP H01227964 A JPH01227964 A JP H01227964A
- Authority
- JP
- Japan
- Prior art keywords
- layer
- antigen
- soln
- bsa
- porous layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 238000004458 analytical method Methods 0.000 title abstract description 7
- 230000001900 immune effect Effects 0.000 title abstract description 4
- 238000006243 chemical reaction Methods 0.000 claims abstract description 12
- 239000011248 coating agent Substances 0.000 claims abstract description 9
- 238000000576 coating method Methods 0.000 claims abstract description 9
- 239000000427 antigen Substances 0.000 claims description 38
- 102000036639 antigens Human genes 0.000 claims description 38
- 108091007433 antigens Proteins 0.000 claims description 38
- 239000000203 mixture Substances 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 17
- 229920001477 hydrophilic polymer Polymers 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 8
- 238000003018 immunoassay Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 9
- 239000012528 membrane Substances 0.000 abstract description 9
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 abstract description 8
- 239000000872 buffer Substances 0.000 abstract description 7
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 abstract description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 abstract description 5
- 229940098773 bovine serum albumin Drugs 0.000 abstract description 5
- 229940034208 thyroxine Drugs 0.000 abstract description 5
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 abstract description 5
- -1 polyethylene terephthalate Polymers 0.000 abstract description 4
- 229920000139 polyethylene terephthalate Polymers 0.000 abstract description 4
- 239000005020 polyethylene terephthalate Substances 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 239000000020 Nitrocellulose Substances 0.000 abstract description 2
- 238000002372 labelling Methods 0.000 abstract description 2
- 229920001220 nitrocellulos Polymers 0.000 abstract description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000004698 Polyethylene Substances 0.000 abstract 1
- 239000012295 chemical reaction liquid Substances 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 229920000573 polyethylene Polymers 0.000 abstract 1
- 230000000284 resting effect Effects 0.000 abstract 1
- 239000010410 layer Substances 0.000 description 137
- 239000003153 chemical reaction reagent Substances 0.000 description 34
- 102000004190 Enzymes Human genes 0.000 description 24
- 108090000790 Enzymes Proteins 0.000 description 24
- 229940088598 enzyme Drugs 0.000 description 24
- 238000001514 detection method Methods 0.000 description 18
- 238000011161 development Methods 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- 238000003892 spreading Methods 0.000 description 10
- 239000007788 liquid Substances 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 7
- 108010010803 Gelatin Proteins 0.000 description 6
- 239000004744 fabric Substances 0.000 description 6
- 229920000159 gelatin Polymers 0.000 description 6
- 239000008273 gelatin Substances 0.000 description 6
- 235000019322 gelatine Nutrition 0.000 description 6
- 235000011852 gelatine desserts Nutrition 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 239000007795 chemical reaction product Substances 0.000 description 5
- 238000006911 enzymatic reaction Methods 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 102000003992 Peroxidases Human genes 0.000 description 3
- 239000012790 adhesive layer Substances 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 239000000123 paper Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 description 3
- 229920002401 polyacrylamide Polymers 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000002759 woven fabric Substances 0.000 description 2
- UTXPWBKKZFLMPZ-UHFFFAOYSA-N 2-aminoacridine Chemical compound C1=CC=CC2=CC3=CC(N)=CC=C3N=C21 UTXPWBKKZFLMPZ-UHFFFAOYSA-N 0.000 description 1
- PDYQQADWTNPTRK-UHFFFAOYSA-N 9h-xanthene-3,6-diol Chemical class C1=C(O)C=C2OC3=CC(O)=CC=C3CC2=C1 PDYQQADWTNPTRK-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 229910001369 Brass Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 239000010951 brass Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000007766 curtain coating Methods 0.000 description 1
- FEQWRQDZXXJRIL-UHFFFAOYSA-N decyl naphthalene-1-sulfonate;sodium Chemical compound [Na].C1=CC=C2C(S(=O)(=O)OCCCCCCCCCC)=CC=CC2=C1 FEQWRQDZXXJRIL-UHFFFAOYSA-N 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 208000028659 discharge Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical group O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 239000010954 inorganic particle Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- KLYWOECPXNAJPC-UHFFFAOYSA-N naphthalen-1-amine;naphthalen-2-amine Chemical compound C1=CC=CC2=CC(N)=CC=C21.C1=CC=C2C(N)=CC=CC2=C1 KLYWOECPXNAJPC-UHFFFAOYSA-N 0.000 description 1
- 239000011146 organic particle Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000010206 sensitivity analysis Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229910000349 titanium oxysulfate Inorganic materials 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical class C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Abstract
Description
【発明の詳細な説明】
[Q明の分野]
本発明は抗原/抗体反応を利用する免疫学的分析にイ1
用な分析要素の製造方法に関する。DETAILED DESCRIPTION OF THE INVENTION [Field of the Invention] The present invention is applicable to immunological analysis using antigen/antibody reactions.
The present invention relates to a method for manufacturing analytical elements for use.
[従来技術]
乾式分析要素を用いて体液などに含右されている生化学
物質を定量する分析方法が知t、れている。[Prior Art] An analytical method for quantifying biochemical substances contained in body fluids using a dry analytical element is known.
乾式分析要素では−・般に、被検成分と分析要素内に含
まれる試薬との反応の反応生成物または未反応成分の量
を、光学的に、例えば発色、変色、蛍光、発光等の分光
測光により測定し、被検成分を定量する。乾式分析要素
を用いると、簡便、迅速に、しかも高い精度で液体中の
特定成分、例えば生化学的活性物質の分析ができる。In dry analytical elements, generally, the amount of reaction products or unreacted components of the reaction between the test component and the reagent contained in the analytical element is measured optically, such as by spectroscopy such as color development, color change, fluorescence, and luminescence. Measure by photometry to quantify the test component. By using a dry analytical element, it is possible to analyze a specific component, such as a biochemically active substance, in a liquid simply, quickly, and with high precision.
乾式分析要素を利用した免疫学的分析も、例えば特開昭
49−53888号、特開昭59−102388号、米
国特許4,459,358号等の記載により知られてい
る。Immunological analysis using dry analytical elements is also known, for example, as described in JP-A-49-53888, JP-A-59-102388, and US Pat. No. 4,459,358.
免疫学における抗原抗体反応は互いに対応する抗原また
は抗体のみに特異的に反応し結かする反応であり、自己
免疫疾患のJ)断、生体内微量物質の検出などに広く利
用されている。しかし操作に熟練を要するため、臨床検
査のためには簡便な操作で精度良く測定できる方法が望
まれている。In immunology, the antigen-antibody reaction is a reaction that specifically reacts and binds only to mutually corresponding antigens or antibodies, and is widely used for diagnosing autoimmune diseases and detecting trace substances in living organisms. However, since it requires skill to operate, a method that can perform accurate measurements with simple operations is desired for clinical testing.
多層分析要素を利用した簡便な抗原量測定法の一つの典
型は特開昭59−77356号に開示されたものである
。この方法で用いている分析要素は、蛍光標識抗原を含
む展開層と、多孔性媒体から成る分配層と、固定化抗体
を禽む反応層を頂層したもので、被検液中の抗原と標工
抗原との間での競争的な抗原抗体反応を利用し、抗原の
量が蛍光強度の減少として測定される。One typical method of simple antigen amount measurement using a multilayer analytical element is disclosed in Japanese Patent Application Laid-Open No. 77356/1983. The analytical element used in this method consists of a development layer containing a fluorescently labeled antigen, a distribution layer consisting of a porous medium, and a reaction layer containing immobilized antibodies on top. The amount of antigen is measured as a decrease in fluorescence intensity using a competitive antigen-antibody reaction between the antigen and the antigen.
また検出感度の比較的高い免疫分析法として、酵素免疫
分析(EIA)が考えられている。典型的な方法は特公
昭53−27763号によって知られ、酵素を抗原また
はその類縁体に結合させて、酵素標識抗原をつくり、酵
素活性に対する抗原の効果の、1111定により、被検
液中の抗原を分析する方法である。この方法では、抗原
と結合しまた酵素標識抗原(Bで示される)と未結合の
酵素標識抗原(Fて示される)とを分mする(いわゆる
B/F分に)か、13と1・゛とで活性が変化する酵素
系が必要とされた。Enzyme immunoassay (EIA) is also considered as an immunoassay method with relatively high detection sensitivity. A typical method is known from Japanese Patent Publication No. 53-27763, in which an enzyme is bound to an antigen or its analog to create an enzyme-labeled antigen, and the effect of the antigen on the enzyme activity is determined by 1111 determination in the sample solution. This is a method of analyzing antigens. In this method, the antigen-bound and enzyme-labeled antigen (denoted by B) and the unbound enzyme-labeled antigen (denoted by F) are separated (into so-called B/F fractions), or 13 and 1. What was needed was an enzyme system whose activity varied depending on the situation.
このような系を成立させるためには、抗体と酵素Iつ品
抗原、:iたは抗体標二1物と抗原類縁体との、いずれ
かの二成分が必須である。検体との接触前にはこれらの
二成分が互いに反応しないようにしておかないと、検出
15度〈信月/背景比)が著しく低下する。これまで知
られた乾式分析要素の多くは、この要因のために満足す
べき分析感度を得ることができなかった。In order to establish such a system, two components are essential: an antibody, an enzyme, an antigen, or an antibody label and an antigen analog. If these two components are not prevented from reacting with each other before contact with the specimen, the detection rate of 15 degrees (shingetsu/background ratio) will drop significantly. Many of the dry analytical elements known so far have not been able to obtain satisfactory analytical sensitivity due to this factor.
[発明の[1的]
本発明の[1的は、高い分析感度と定量分析精度を有す
る、乾式免疫7的分析要素の製造方法の提供にある。[1st aspect of the invention] [1st aspect of the present invention] The first aspect of the present invention is to provide a method for producing a dry immunoanalytical element having high analytical sensitivity and quantitative analysis accuracy.
[発明の構成]
本発明の上記目的は、少なくとも一−一)の水浸透性の
多孔性層を有し、抗原/抗体反応に関与する成分として
抗原類縁体と標識抗体とを前記多孔性層に含む酵素活性
測定用乾式分析要素を製造するに際し、多孔性層に、前
記抗原類縁体を含む組成物と前記標識抗体を含む組成物
とを個別に塗布または含浸することにより、達成された
。前記2つの組成物は、極性の異なる溶媒(例えば水と
エチルアルコール)からそれぞれ成ることが好ましい。[Structure of the Invention] The above-mentioned object of the present invention is to have at least 1-1) water-permeable porous layer, and contain an antigen analog and a labeled antibody as components involved in an antigen/antibody reaction in the porous layer. This was achieved by separately coating or impregnating a porous layer with a composition containing the antigen analog and a composition containing the labeled antibody. Preferably, the two compositions each consist of solvents with different polarities (eg, water and ethyl alcohol).
特に抗原類縁体、前記標識抗体のいずれか一方を含む第
1の組成物を塗布または含浸した後、他の一方を含み親
水性高分子を膨潤させない溶媒から成る第2の組成物を
多孔性層に塗布または含浸する方法は、有用な方法の一
つである。親水性高分子を膨潤させない溶媒としては、
例えば低級アルコール類(例えばメチルアルコール、エ
チルアルコール)、エーテル類、ケトン類(例えばアセ
トン)のような有機溶媒が有用である。第1の組成物に
用いる溶媒としては、水が好ましいが、前記のような有
機溶媒を用いてもよい。In particular, after applying or impregnating a first composition containing either an antigen analog or the labeled antibody, a second composition containing the other one and consisting of a solvent that does not swell the hydrophilic polymer is applied to a porous layer. One of the useful methods is to apply or impregnate. As a solvent that does not swell hydrophilic polymers,
Organic solvents such as lower alcohols (eg methyl alcohol, ethyl alcohol), ethers, ketones (eg acetone) are useful. The solvent used in the first composition is preferably water, but organic solvents such as those mentioned above may also be used.
抗原類縁体とは、抗原に対する抗体に、抗原と同様に結
合することのできる物質を言う。例えば、抗原と蛋白質
との化字的結合物、抗原とラテックスとの物理的結合物
、抗原と固体担体との結合物である。An antigen analog refers to a substance that can bind to an antibody against the antigen in the same way as the antigen. Examples include a literal combination of an antigen and a protein, a physical combination of an antigen and latex, and a combination of an antigen and a solid support.
抗原類縁体を含む組成物と、前記標識抗体を含む組成物
と(いずれか一方は水溶液、いずれが−方は親水性高分
子を膨潤させない溶媒から成る)をそれぞれ予め含浸ま
たは塗布した多孔性展開層を、他の水浸透性層、例えば
試薬層の土に、特開昭55−164356号のような方
法で接着させるのも有用な方法である。A porous expander pre-impregnated or coated with a composition containing an antigen analog and a composition containing the labeled antibody (one of which is an aqueous solution and the other of which is a solvent that does not swell the hydrophilic polymer). It is also a useful method to adhere the layer to another water-permeable layer, such as the soil of the reagent layer, as in JP-A-55-164356.
また抗原類縁体を含む組成物と標識抗体を含む組成物と
をそれぞれ予め含浸、塗布等により含有した多孔性層を
、他の多孔性層(PAえば試薬層)の上に、例えば特開
昭61−4959号等のような方法で接着させる方法も
有用である。Furthermore, a porous layer containing a composition containing an antigen analog and a composition containing a labeled antibody by impregnation, coating, etc. in advance is placed on top of another porous layer (for example, a reagent layer for PA). A method of adhesion such as that disclosed in No. 61-4959 is also useful.
別の方法として、抗原類縁体を含む第1の組成物(例え
ば水溶液)を予め含浸または塗布した多孔性層(例えば
展開層)を、他の水浸透性層(例えば試薬層)の上に前
記のような方法で接着させた後、標識抗体を含む第2の
組成物を多孔性層に塗布してもよい。Alternatively, a porous layer (e.g., a spreading layer) pre-impregnated or coated with a first composition (e.g., an aqueous solution) containing an antigen analog may be placed on top of another water-permeable layer (e.g., a reagent layer). After adhesion by a method such as, a second composition containing a labeled antibody may be applied to the porous layer.
反対に、標識抗体を含む組成物を多孔性層に含浸させ、
池の層に接着後、抗原類縁体を含む組成物を塗布しても
よい。Conversely, impregnating a porous layer with a composition containing a labeled antibody,
After adhering to the pond layer, a composition containing an antigen analog may be applied.
多孔性層への含浸または塗布には公知の方法を利用でき
る。塗布には例えばデイツプ塗布、ドクター塗布、ホッ
パー塗布、カーテン塗布等を適宜選択して用いる。Known methods can be used for impregnating or coating the porous layer. For example, dip coating, doctor coating, hopper coating, curtain coating, etc. are selected and used as appropriate.
本発明における多孔性層は、分析要素の最上層であって
もよいし、最上層と試薬層の間にある層でもよい、供給
される液体の量にほぼ比例した面積に液体を展開する、
いわゆる計量作用を有する液体展開層(以下、展開層と
いうことがある)であってもよいし、それ以外でもよい
、繊維質であってもよいし、非繊維質でもよい、天然繊
維から成る布、合成または半合成m維から成る布、不織
布、紙、酢酸セルロース等から成るメンブランフィルタ
−1無機物または有機物粒子の結合体等のいずれでもよ
い0例えば特開昭55−164356号、同60−22
2769号等に記載された繊維質層のほか、特開昭49
−53888号、特開昭58−70163号、同61−
4959号、特願昭60−256408号、同60−2
79859号、同60−279860号、同60−27
9861号等に記載されたような多孔性層も好適である
。The porous layer in the present invention may be the uppermost layer of the analytical element, or may be a layer between the uppermost layer and the reagent layer, and spreads the liquid over an area approximately proportional to the amount of liquid supplied.
A fabric made of natural fibers, which may be a liquid spreading layer having a so-called metering effect (hereinafter sometimes referred to as the spreading layer) or may be other than that, and may be fibrous or non-fibrous. Membrane filter made of cloth, nonwoven fabric, paper, cellulose acetate, etc. made of synthetic or semi-synthetic fibers 1 Any combination of inorganic or organic particles may be used. For example, JP-A-55-164356, JP-A-60-22
In addition to the fibrous layer described in No. 2769, etc., JP-A-49
-53888, JP-A No. 58-70163, JP-A No. 61-
No. 4959, Patent Application No. 60-256408, No. 60-2
No. 79859, No. 60-279860, No. 60-27
Porous layers such as those described in US Pat. No. 9,861 are also suitable.
抗体を蛍光標識するためには種々の蛍光物質を用いるこ
とができる。それらは官能成分により分類することがで
きるが、例えばアミン基を有する蛍光物質として
1−アミノナフタレン
2−アミノナフタレン
p、p’−ジアミノスヂルベン
2−アミノアクリジン
p、p’−ジアミノベンゾフェノンイミン類ビス−3−
アミノピリジニウム塩
インドール類
フェノール性蛍光物質として
7−ヒドロキシクマリン類
3.6−ジヒドロキシキサンテン類
テトラサイクリン
サリチル酸エステル類
等が挙げられる0代表的なものはフルオレセインである
。Various fluorescent substances can be used to fluorescently label antibodies. They can be classified according to their functional components, and for example, fluorescent substances with amine groups include 1-aminonaphthalene 2-aminonaphthalene p, p'-diaminosdilbene 2-aminoacridine p, and p'-diaminobenzophenonimine. Bis-3-
Aminopyridinium salts Indoles Examples of the phenolic fluorescent substances include 7-hydroxycoumarins, 3,6-dihydroxyxanthenes, tetracycline salicylic acid esters, etc. A typical example is fluorescein.
抗体は発光物質、例えば化学発光物質で標識されてもよ
い0例えば、ルミノールで代表される2)3−ジヒドロ
−1,4−フタラジンジオン、あるいは2.4.5−
)リフェニルイミダゾール類を用いることができる。The antibody may be labeled with a luminescent substance, such as a chemiluminescent substance, such as 2) 3-dihydro-1,4-phthalazinedione, typified by luminol, or 2.4.5-
) Riphenylimidazoles can be used.
抗体を酵素標識する場合、種々の酵素を用いることがで
きる。充分高い酵素活性が得られること、酵素の安定性
、酵素活性への結合の影響等を考慮して、酵素が選択さ
れる。特表昭56−500901号明細書の第1表およ
び第2表に記載されたものから選ぶことができる0代表
的なものはグルコースオキシダーゼ(COD )、β−
D−ガラクトシダーゼ、ペルオキシダーゼ(POD)、
アルカリ性ホスファターゼ(ALP)、α−アミラーゼ
、ルシフェラーゼ等である。When enzymatically labeling antibodies, various enzymes can be used. Enzymes are selected taking into consideration the ability to obtain sufficiently high enzyme activity, the stability of the enzyme, the influence of binding on enzyme activity, and the like. Typical examples include glucose oxidase (COD), β-
D-galactosidase, peroxidase (POD),
These include alkaline phosphatase (ALP), α-amylase, and luciferase.
抗体に標識を結合させる方法および本発明に用いること
ができる標識抗体については、石川栄治ら二「酵素免疫
測定法(第2版)J(1982年)河合忠Ii:「臨床
検査技術金言4免疫血清検査」(医学書院、1977年
発行)、97−102頁、B 1ocl+em、 I3
1opl+ys 、 Res 、 Coaemun 、
、74.538(1977)、Cl1nica Ch
imica Acta 、83,161(1978)等
の記載が参照できる。Regarding the method of binding a label to an antibody and the labeled antibody that can be used in the present invention, please refer to Eiji Ishikawa et al., "Enzyme immunoassay (2nd edition) J (1982)," Tadashi Kawai, II: "Clinical Test Techniques 4 Immunology." Serum Test” (Igakushoin, published in 1977), pp. 97-102, B 1ocl+em, I3
1opl+ys, Res, Coaemun,
, 74.538 (1977), Clnica Ch.
Reference may be made to the descriptions in Imica Acta, 83, 161 (1978) and the like.
標識抗体の具体例としてフルオレセインイソチオシアネ
ー)(FrTC)結合チロキシン(T、)抗体、GOD
結合抗ヒト免疫グロブリン(I gG)、ALP結合抗
I gG、POD標識抗α−フェトプロティン等がある
。Specific examples of labeled antibodies include fluorescein isothiocyanate (FrTC)-conjugated thyroxine (T) antibody, GOD
Examples include conjugated anti-human immunoglobulin (IgG), ALP-conjugated anti-IgG, and POD-labeled anti-α-fetoprotein.
酵素標識抗体を用いる場合、抗原/抗体反応の結果を測
定するために、酵素活性の測定を必要とし、酵素の基質
、酵素反応生成物の検出系が必要とされる。基質は標識
抗体と同一の層中に存在してもよいが、異なる層の中に
含まれるのが好ましい。基質または酵素標識抗体の少な
くとも一方を、酵素標識抗体の酵素反応が実質的に起こ
らない溶媒を用いて塗布または含浸することが好ましい
。When using an enzyme-labeled antibody, it is necessary to measure the enzyme activity in order to measure the result of the antigen/antibody reaction, and a detection system for the enzyme substrate and enzyme reaction product is required. Although the substrate may be present in the same layer as the labeled antibody, it is preferably contained in a different layer. It is preferred that at least one of the substrate or the enzyme-labeled antibody is coated or impregnated with a solvent in which the enzymatic reaction of the enzyme-labeled antibody does not substantially occur.
基質と酵素反応生成物の検出系とは、同一層中に存在し
てもよく、また異なる層の中に含まれてもよい、基質が
自己顕色性基質である場合には、酵素反応生成物の検出
系は特に必要としない。The detection system for the substrate and the enzyme reaction product may be present in the same layer or in different layers. No particular object detection system is required.
本発明は公知の多種の乾式分析要素に適用することが出
来る。要素は多孔性層、試薬層のほか、支持体、展rM
J1!!、検出層、光遮蔽層、接着層、ろ過層、吸水層
、下塗り層その他の層を含む多重層の構成を有してもよ
い、かような分析要素として、米国特許第3,992,
158号、同4,042,335号および特開昭55−
164356号各明細書に開示されたものがある。The present invention can be applied to various known dry analysis elements. The elements include a porous layer, a reagent layer, a support, and a spreading layer.
J1! ! , a detection layer, a light-shielding layer, an adhesive layer, a filtration layer, a water-absorbing layer, a subbing layer, and other layers.
No. 158, No. 4,042,335 and JP-A-55-
There are some disclosed in each specification of No. 164356.
光透過性水不透過性支持体を用いる場合、本発明の乾式
分析要素の実用的に採りうる構成は〈1)支持体上に試
薬層、その上に展rM層を有するもの。When using a light-transparent water-impermeable support, practical configurations of the dry analytical element of the present invention include (1) a reagent layer on the support and a spreading rM layer thereon;
(2)支持体上に検出層、試薬層、展開層をこの順に有
するもの。(2) A device having a detection layer, a reagent layer, and a developing layer in this order on a support.
(3)支持体上に試薬層、光反射層、展開層をこの順に
有するもの。(3) One having a reagent layer, a light reflecting layer, and a developing layer in this order on a support.
(4)支持体上に検出層、試薬層、光反射層、展開層を
この順に有するもの。(4) A support having a detection layer, a reagent layer, a light reflection layer, and a development layer in this order.
(5)支持体上に検出層、光反射層、試薬層、展開層を
この原に有するもの。(5) One that has a detection layer, a light reflection layer, a reagent layer, and a development layer on the support.
(6)支持体上に第二試薬層、光反射層、第一試薬層、
展開層をこの順に有するもの。(6) a second reagent layer, a light reflection layer, a first reagent layer on the support,
It has development layers in this order.
(7)支持体上に検出層、第二試薬層、光反射層、第一
試薬層、展開層をこの順に有するもの。(7) A support having a detection layer, a second reagent layer, a light reflection layer, a first reagent layer, and a developing layer in this order.
検出層は一般に被検成分の存在下で生成した色素等が拡
散し、光透過性支持体を通して光学的に検出され得る層
で、親水性ポリマーにより構成することができる0色素
に対する媒染剤、例えばアニオン性色素に対してカチオ
ン性ポリマーを、含んでもよい。The detection layer is generally a layer in which a dye generated in the presence of a test component diffuses and can be optically detected through a light-transmitting support, and is a layer that can be composed of a hydrophilic polymer and contains a mordant for the dye, such as an anion. A cationic polymer may also be included for the coloring matter.
吸水層は一般に、被検成分の存在下で生成する色素が実
質的に拡散しないような層を言い、膨潤しやすい親水性
ポリマーにより構成することができる。The water-absorbing layer generally refers to a layer in which a dye generated in the presence of a test component does not substantially diffuse, and can be composed of a hydrophilic polymer that easily swells.
抗原類縁体および標識抗体が含まれる層は、展開層ある
いは試薬層であってもよい。The layer containing the antigen analog and labeled antibody may be a spreading layer or a reagent layer.
酵素標識抗体を用いる場合に酵素反応生成物を検出する
ための試薬組成物は、抗原類縁体および標識抗体を含む
層に含まれてもよいが、別の無孔性層または多孔性層に
含有させてもよい。例えば酵素反応生成物との反応によ
り中間体を生成する組成物を第1の試薬層に、中間体と
反応して染料等を生成し得る組成物(指示薬)を試薬層
と支持体との間にある第2の試薬層に含んでもよい、ま
た前記の中間体を生成する組成物を試薬層より支持体か
ら遠い層、例えば展fm層等に含み、指示薬を試薬層に
含んでもよい。When using an enzyme-labeled antibody, the reagent composition for detecting the enzyme reaction product may be contained in the layer containing the antigen analog and the labeled antibody, but it may also be contained in a separate non-porous or porous layer. You may let them. For example, a composition that produces an intermediate by reaction with an enzyme reaction product is placed in the first reagent layer, and a composition (indicator) that can react with the intermediate to produce a dye or the like is placed between the reagent layer and the support. Alternatively, the composition for producing the intermediate may be contained in a layer farther from the support than the reagent layer, for example, the spreading fm layer, and the indicator may be contained in the reagent layer.
上記(1)ないしく5)において試薬層はそれぞれ異な
る複数の層から成ってもよい。支持体と試薬層または検
出層との間には吸水層を設けてもよい、上記(1)ない
しく3)と(6)において試薬層と検出層または展開層
の間にろ過層を設けてもよい、上記(3)ないしく7)
において光反射層と検出層、試薬層または展開層との間
、試薬層と検出層との間または試薬層と展開層との間に
、さらにろ過層を設けてもよい、試薬層が複数層から成
る場合に、試薬層と試薬層の間にさらにろ過層を設けて
もよい。In (1) to 5) above, the reagent layer may consist of a plurality of different layers. A water absorption layer may be provided between the support and the reagent layer or the detection layer. In (1) or 3) and (6) above, a filtration layer may be provided between the reagent layer and the detection layer or the development layer. Good, above (3) or 7)
A filtration layer may be further provided between the light reflection layer and the detection layer, the reagent layer or the development layer, between the reagent layer and the detection layer, or between the reagent layer and the development layer. In this case, a filtration layer may be further provided between the reagent layers.
光透過性水不透過性支持体の材料として好ましいものは
ポリエチレンテレフタレートである。親水性層を強固に
接着させるため通常、下塗り層を設けるか、親水化処理
を施す。A preferred material for the light-transparent, water-impermeable support is polyethylene terephthalate. In order to firmly adhere the hydrophilic layer, an undercoat layer is usually provided or a hydrophilic treatment is applied.
本発明の乾式分析要素の試薬層としては、親水性ポリマ
ーを結合剤とする実質的に均一の層のほか、例えば特開
昭58−70163号、特開昭61−4959号、特願
昭60−256408号、同60−279859号、同
60−279860号、同60−279861号等に記
載されたような多孔性層も好適である。FA水性ポリマ
ーとして例えば、ゼラチンおよびこれらの誘導体く例え
ばフタル化ゼラチン)、セルロース誘導体(例えばヒド
ロキシメチルセルロース)、アガロース、アクリルアミ
ド重合体、メタアクリルアミド重合体、アクリルアミド
またはメタアクリルアミドと各種ビニル性モノマーとの
共重合体等が利用できる。As the reagent layer of the dry analytical element of the present invention, in addition to a substantially uniform layer containing a hydrophilic polymer as a binder, examples include JP-A-58-70163, JP-A-61-4959, and JP-A-Sho 60. Porous layers such as those described in No. 256408, No. 60-279859, No. 60-279860, No. 60-279861 are also suitable. Examples of FA aqueous polymers include gelatin and derivatives thereof (e.g. phthalated gelatin), cellulose derivatives (e.g. hydroxymethylcellulose), agarose, acrylamide polymers, methacrylamide polymers, copolymers of acrylamide or methacrylamide with various vinyl monomers. Combination etc. can be used.
試薬層には必要に応じ酵素に対する基質、酸化剤、カプ
ラー、緩衝剤等を含有させることができる。標識抗体と
して酵素標識抗体を含む場合には、当該酵素に対する基
質が必須である。The reagent layer can contain a substrate for the enzyme, an oxidizing agent, a coupler, a buffer, etc., if necessary. When an enzyme-labeled antibody is included as a labeled antibody, a substrate for the enzyme is essential.
本発明の分析要素の試薬層に含有させることができる緩
衝剤の例としては、炭酸塩、ホウ酸塩、燐酸塩やBio
chemistry誌 第5巻 第2号、467ページ
より477ページ(1966年)に記載されているグツ
ド(Good )の緩衝剤などを挙げることができる。Examples of buffers that can be contained in the reagent layer of the analytical element of the present invention include carbonates, borates, phosphates, and
Examples include the buffering agent of Good, which is described in Chemistry Magazine, Vol. 5, No. 2, pages 467 to 477 (1966).
これらの緩衝剤はr蛋白質・酵素の基礎実験法1(堀尾
武−ほか著、南江堂、1981年)、前記Biocl+
emistry誌第5巻等の文献を参考にして選択する
ことができる。These buffers are described in Basic Experimental Methods for r-Proteins and Enzymes 1 (Takeshi Horio et al., Nankodo, 1981), the above-mentioned Biocl+
The selection can be made by referring to literature such as volume 5 of emistry magazine.
多孔性層を展開層として利用する場合、液体計量作用を
有する層であることが好ましい、液体計量作用とは、そ
の表面に点着供給された液体試料を、その中に含有して
いる成分を実質的に偏在させることなく、面の方向に単
位面積当りほぼ一定量の割合で広げる作用である。When a porous layer is used as a spreading layer, it is preferable that the layer has a liquid metering function.The liquid metering function refers to a layer that collects the components contained therein by dropping a liquid sample onto its surface. This is an effect of spreading the particles in the direction of the surface at a rate of a substantially constant amount per unit area without substantially unevenly distributing the particles.
展t7F1層その他の多孔性層を構成する材料としては
、P紙、不織布、織物生地(例えば平織生地)、編物生
地(例えば、トリコット編)、ガラス繊維2紙等を用い
ることができる。展開層としては、これらのうち織物、
編物等が好ましい、織物等は特開昭57−66359号
に記載されたようなグロー放電処理をしてもよい、展開
層には、展開面精、展開速度等を調節するため、特開昭
60−222770号、特願昭61−122875号、
61−122876号、61−143754号に記載し
たような親水性高分子あるいは界面活性剤を含有しても
よい。As materials constituting the expanded T7F1 layer and other porous layers, P paper, nonwoven fabric, woven fabric (for example, plain weave fabric), knitted fabric (for example, tricot fabric), glass fiber 2 paper, etc. can be used. Among these, textiles,
Knitted fabrics are preferred. Woven fabrics may be subjected to glow discharge treatment as described in JP-A No. 57-66359. For the spreading layer, in order to adjust the development surface finish, development speed, etc., No. 60-222770, patent application No. 122875-1987,
It may contain a hydrophilic polymer or a surfactant as described in Nos. 61-122876 and 61-143754.
多孔性層を接着し頂層するための接着層を、試薬層、光
道へい層、濾過層、吸水層、検出層等の層の上に設けて
もよい、接着層は水で膨潤したときに多孔性層を接着す
ることができるような親水性ポリマー、例えばゼラチン
、ゼラチン誘導体、ポリアクリルアミド、澱粉等からな
ることが好ましい。An adhesive layer for adhering and top layering the porous layer may be provided on layers such as a reagent layer, a light guide layer, a filtration layer, a water absorption layer, a detection layer, etc. When the adhesive layer is swollen with water, Preferably, it consists of a hydrophilic polymer to which the porous layer can be adhered, such as gelatin, gelatin derivatives, polyacrylamide, starch, etc.
光遮蔽層は、検出層、試薬層等に生じた検出可能な変化
(色変化、発色等)を光透過性を有する支持体側から反
射測光する際に、展開層に点着供給された被検液の色、
特に試料が全血である場合のヘモグロビンの赤色等を遮
蔽するとともに光反射層または背景層として機能する。The light-shielding layer is used to measure the detectable changes (color change, color development, etc.) that occur in the detection layer, reagent layer, etc. from the light-transmitting support side. liquid color,
Particularly when the sample is whole blood, it blocks the red color of hemoglobin and functions as a light reflecting layer or background layer.
光遮蔽層は、皮膜形成能を有する親水性ポリマーをバイ
ンダーとして、酸化チタン、硫酸バリウム等の光反射性
微粒子が分散された水浸透性の層であることが好ましい
、バインダーとしてはゼラチン、ゼラチン誘導体、ポリ
アクリルアミド等が好ましい0分析要素には、光遮蔽層
を設ける代わりに、またはそれと同時に、展開層、試薬
層、検出層等に酸化チタン等の光反射粒子を含有させて
もよい。The light shielding layer is preferably a water-permeable layer in which light-reflecting fine particles such as titanium oxide and barium sulfate are dispersed using a hydrophilic polymer having a film-forming ability as a binder.The binder is gelatin or a gelatin derivative. , polyacrylamide, and the like, light-reflecting particles such as titanium oxide may be included in the developing layer, reagent layer, detection layer, etc. instead of or simultaneously with the light-shielding layer.
[実施例]
(1)T、−BSAの合成
牛血清アルブミン(BSA)15mgを3mlのりん酸
MHIt液(pH8,0,0,1M)に溶解し、これに
T、溶液(チロキシン10mgを3mlのジメチルスル
フオキシドに溶解したもの)を靜かに添加した0次にこ
の液に1%ゲルタールアルデヒド溶液0.2mlをゆっ
くりと添加し、4℃で3時間反応させた。反応液を2日
間透析し、凍結乾燥してT4−BSAを得た。[Example] (1) Synthesis of T, -BSA 15 mg of bovine serum albumin (BSA) was dissolved in 3 ml of phosphate MHIt solution (pH 8, 0, 0, 1 M), and 3 ml of T, solution (thyroxine 10 mg) To this solution, 0.2 ml of 1% geltaraldehyde solution was slowly added and reacted at 4° C. for 3 hours. The reaction solution was dialyzed for 2 days and lyophilized to obtain T4-BSA.
(2)抗原固定化膜の作製
ニトロセルロースメンブランフィルタ−(ミリボア社製
)に下記の液(λ)を含浸し、1夜放置した後、水でよ
く洗浄した。(2) Preparation of antigen-immobilized membrane A nitrocellulose membrane filter (manufactured by Millibore) was impregnated with the following solution (λ), left overnight, and then thoroughly washed with water.
(A) 74 BSA(上記) 15μg炭
酸緩衝液(pH9) 10社
次にこのメンブランフィルタ−に、BS A 300m
gを水Loafに溶解した液を含浸し、1夜放置した後
、水でよく洗浄して、室温で乾燥したものを抗原固定化
膜とした。(A) 74 BSA (above) 15 μg carbonate buffer (pH 9) 10 companies Next, add 300 m of BSA to this membrane filter.
The membrane was impregnated with a solution of Loaf g dissolved in water Loaf, left overnight, thoroughly washed with water, and dried at room temperature to obtain an antigen-immobilized membrane.
(3)T4測定要素の作製
前記抗原固定化膜に下記組成(C)の液を含浸した後、
速やかに乾燥した(FITCはフルオレセインイソチオ
シアネートを意味する)。(3) Preparation of T4 measurement element After impregnating the antigen-immobilized membrane with a solution having the following composition (C),
Dry quickly (FITC means fluorescein isothiocyanate).
(C)FITC標識抗標識抗体溶液 1m1(抗体乾燥
粉末40μg含有)
エタノール 9醜!
次にこれを厚さ180μ−のPET支持体に特開昭62
−138756実施例3に記載された方法により点状部
分接着した。15mm角に裁断し、上下に直径10g+
−の窓を設けたポリスチレンフレームにはさみ込み、T
、測定要素[1]とした。(C) FITC-labeled anti-labeled antibody solution 1ml (contains 40μg of antibody dry powder) Ethanol 9 Ugly! Next, this was placed on a PET support with a thickness of 180μ.
-138756 The dotted portions were adhered by the method described in Example 3. Cut into 15mm squares, top and bottom diameter 10g+
- Insert into a polystyrene frame with a window, T
, was defined as the measurement element [1].
一方、抗原固定化膜に含浸する液の組成(C)を下記(
D)に変更した他は上記T、測定要素と同様にして、比
較用T4測定要素[2]を作製した。On the other hand, the composition (C) of the solution to be impregnated into the antigen-immobilized membrane is as follows (
A comparative T4 measurement element [2] was prepared in the same manner as the above T measurement element except for changing to D).
(D)FITC標識抗標識抗体4抗 (抗体乾燥粉末40μg含有) 蒸留水 9鍮! (4)チロキシンの測定 チロキシン(T,)を含まない血清に既知量のT。(D) FITC-labeled anti-labeled antibody 4 anti (Contains 40 μg of antibody dry powder) Distilled water 9 brass! (4) Measurement of thyroxine A known amount of T in serum that does not contain thyroxine (T,).
を添加したT,含有血清5μlに、0.3MグリシンM
衝液(pH9.0、0.05MFデシルナフタレンスル
フォン酸ナトリウム含有)5μlを加えたものを、各分
析要素に点着(滴下)した、37℃で15分間放置後、
各分析要素に0.3MグリシンM衝液(上記に同じ)
15μlを滴下して拭き取る操作を2回繰り返し、遊離
のFITC標識抗体を洗い流した。0.3M glycine M was added to 5 μl of serum containing T.
Added 5 μl of buffer solution (pH 9.0, containing 0.05 MF sodium decylnaphthalene sulfonate) and spotted (dropped) it on each analytical element. After leaving it at 37°C for 15 minutes,
0.3M glycine M buffer for each analytical element (same as above)
The operation of dropping 15 μl and wiping was repeated twice to wash away free FITC-labeled antibody.
その後、蛍光光度計(日立製作所モデル650−10(
S))を用い、励起波長495ns、蛍光波長525n
mで、PET支持体側より蛍光を測定した.得られた結
果を第1図に示す。Then, use a fluorometer (Hitachi model 650-10 (
S)), excitation wavelength 495ns, fluorescence wavelength 525n
Fluorescence was measured from the PET support side. The results obtained are shown in FIG.
第1図から明らかなように、本発明の分析要素[1]は
比較用分析要素[2]に比し、優れた免疫分析特性を示
した。As is clear from FIG. 1, the analytical element [1] of the present invention exhibited superior immunoassay properties compared to the comparative analytical element [2].
第1図はT4測定用分析要素の免疫分析特性を示すグラ
フである。
出願人: 富士写真フィルム株式会社FIG. 1 is a graph showing the immunoassay characteristics of the analytical element for T4 measurement. Applicant: Fuji Photo Film Co., Ltd.
Claims (3)
原/抗体反応に関与する成分として、抗原類縁体と標識
抗体とを前記多孔性層に含む乾式免疫分析要素の製造方
法であって、 多孔性層に、前記抗原類縁体を含む組成物と前記標識抗
体を含む組成物とを、個別に塗布または含浸することを
特徴とする乾式分析要素の製造方法。(1) A method for producing a dry immunoassay element, which has at least one water-permeable porous layer and contains an antigen analog and a labeled antibody in the porous layer as components involved in antigen/antibody reactions. A method for producing a dry analytical element, comprising separately applying or impregnating a composition containing the antigen analog and a composition containing the labeled antibody onto the porous layer.
抗原類縁体を含む組成物を塗布または含浸した後、前記
標識抗体を含み親水性高分子を膨潤させない溶媒から成
る組成物を該多孔性層に塗布または含浸することを特徴
とする方法。(2) In claim (1), after coating or impregnating the porous layer with the composition containing the antigen analogue, a composition containing the labeled antibody and comprising a solvent that does not swell the hydrophilic polymer is applied to the porous layer. A method characterized by coating or impregnating a porous layer.
含む組成物を塗布または含浸した後、前記抗原類縁体を
含み親水性高分子を膨潤させない溶媒から成る組成物を
該多孔性層に塗布または含浸することを特徴とする方法
。(3) In claim (1), after applying or impregnating the composition containing the labeled antibody, a composition containing the antigen analog and comprising a solvent that does not swell the hydrophilic polymer is applied to the porous layer. A method characterized by coating or impregnating.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5558988A JPH01227964A (en) | 1988-03-09 | 1988-03-09 | Production of immunological analysis element |
US07/320,771 USH1664H (en) | 1988-03-09 | 1989-03-08 | Analytical element for immunoassay and method for its preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5558988A JPH01227964A (en) | 1988-03-09 | 1988-03-09 | Production of immunological analysis element |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01227964A true JPH01227964A (en) | 1989-09-12 |
Family
ID=13002938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5558988A Pending JPH01227964A (en) | 1988-03-09 | 1988-03-09 | Production of immunological analysis element |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01227964A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006023725A3 (en) * | 2004-08-19 | 2006-05-18 | Blood Cell Storage Inc | FLUORESCENT pH DETECTOR SYSTEM AND RELATED METHODS |
US8183052B2 (en) | 2004-08-19 | 2012-05-22 | Blood Cell Storage, Inc. | Methods and apparatus for sterility testing |
US8497134B2 (en) | 2004-08-19 | 2013-07-30 | Blood Cell Storage, Inc. | Fluorescent detector systems for the detection of chemical perturbations in sterile storage devices |
US9040307B2 (en) | 2011-05-27 | 2015-05-26 | Blood Cell Storage, Inc. | Fluorescent pH detector system and related methods |
-
1988
- 1988-03-09 JP JP5558988A patent/JPH01227964A/en active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006023725A3 (en) * | 2004-08-19 | 2006-05-18 | Blood Cell Storage Inc | FLUORESCENT pH DETECTOR SYSTEM AND RELATED METHODS |
US7608460B2 (en) | 2004-08-19 | 2009-10-27 | Blood Cell Storage, Inc. | Fluorescent pH detector system and related methods |
US7968346B2 (en) | 2004-08-19 | 2011-06-28 | Blood Cell Storage, Inc. | Fluorescent pH detector system and related methods |
US8148167B2 (en) | 2004-08-19 | 2012-04-03 | Blood Cell Storage, Inc. | Fluorescent pH detector system and related methods |
US8183052B2 (en) | 2004-08-19 | 2012-05-22 | Blood Cell Storage, Inc. | Methods and apparatus for sterility testing |
US8497134B2 (en) | 2004-08-19 | 2013-07-30 | Blood Cell Storage, Inc. | Fluorescent detector systems for the detection of chemical perturbations in sterile storage devices |
US9217170B2 (en) | 2004-08-19 | 2015-12-22 | Blood Cell Storage, Inc. | Fluorescent detector systems for the detection of chemical perturbations in sterile storage devices |
US10156578B2 (en) | 2004-08-19 | 2018-12-18 | Blood Cell Storage, Inc. | Fluorescent detector systems for the detection of chemical perturbations in sterile storage devices |
US9040307B2 (en) | 2011-05-27 | 2015-05-26 | Blood Cell Storage, Inc. | Fluorescent pH detector system and related methods |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4587102A (en) | Multi-layer analysis element utilizing specific binding reaction | |
US5160486A (en) | Test carrier utilizing reaction of two bioaffine binding partners | |
US4613567A (en) | Immunoassay method for measuring immunological antigen in fluid sample | |
US5110550A (en) | Test carrier for the analytical determination of a component of a liquid sample | |
US7384796B2 (en) | Assays | |
US4340564A (en) | Immunoadsorptive surface coating for solid-phase immunosubstrate and solid-phase immunosubstrate | |
JPH01113662A (en) | Specific bond assay apparatus and method | |
US4975366A (en) | Multi-layered element for quantititative analysis of immuno reactant | |
JPS6319559A (en) | Immune analysis method | |
US5569589A (en) | Immunoassay element and process and immunoassay | |
US5958339A (en) | Format for immunoassay in thin film | |
JPH0726960B2 (en) | Dry whole blood analysis element | |
US5266460A (en) | Method of preparing immunological analytical element | |
JP4437211B2 (en) | Measuring method using immunochromatography and sample analysis tool used therefor | |
JPH01227964A (en) | Production of immunological analysis element | |
JP2001228151A (en) | Immunological chromatographic device | |
JP2576913B2 (en) | Immunoassay element and immunoassay method | |
JPH01229968A (en) | Dry type immunity analysis element | |
WO2004081528A2 (en) | Assay device and method | |
USH1664H (en) | Analytical element for immunoassay and method for its preparation | |
JPH01237455A (en) | Dry immunity analyzing element | |
JPH0191795A (en) | Analytical element | |
JPS63221246A (en) | Dry type immunoassary element | |
JPS63228068A (en) | Production of immunological analysis element | |
JPH0238971A (en) | Reagent for enzyme immunoassay and enzyme immunoassay using this reagent |